Calyxt is a plant-based synthetic biology company that utilizes its proprietary PlantSpring technology platform to engineer plant metabolism to produce materials and products. Co. is focused on developing synthetic biology solutions through its PlantSpring technology platform for manufacture using its proprietary and differentiated BioFactory production system across a range of end markets, including the cosmeceutical, nutraceutical, and pharmaceutical industries. Co. also out-licenses elements of the PlantSpring technology platform and may selectively develop products in agriculture. Co.'s product, an improved digestibility alfalfa, was developed with and licensed to S&W Seed Company.
|
Free CLXT Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: CLXT Stock Forecast Based on Zacks ABR data; powered by Xignite |